Department of Medical Biophysics, University of Toronto;
Department of Medical Biophysics, University of Toronto.
J Vis Exp. 2024 Apr 12(206). doi: 10.3791/66383.
Preclinical intravital imaging such as microscopy and optical coherence tomography have proven to be valuable tools in cancer research for visualizing the tumor microenvironment and its response to therapy. These imaging modalities have micron-scale resolution but have limited use in the clinic due to their shallow penetration depth into tissue. More clinically applicable imaging modalities such as CT, MRI, and PET have much greater penetration depth but have comparatively lower spatial resolution (mm scale). To translate preclinical intravital imaging findings into the clinic, new methods must be developed to bridge this micro-to-macro resolution gap. Here we describe a dorsal skinfold window chamber tumor mouse model designed to enable preclinical intravital and clinically applicable (CT and MR) imaging in the same animal, and the image analysis platform that links these two disparate visualization methods. Importantly, the described window chamber approach enables the different imaging modalities to be co-registered in 3D using fiducial markers on the window chamber for direct spatial concordance. This model can be used for validation of existing clinical imaging methods, as well as for the development of new ones through direct correlation with "ground truth" high-resolution intravital findings. Finally, the tumor response to various treatments-chemotherapy, radiotherapy, photodynamic therapy-can be monitored longitudinally with this methodology using preclinical and clinically applicable imaging modalities. The dorsal skinfold window chamber tumor mouse model and imaging platforms described here can thus be used in a variety of cancer research studies, for example, in translating preclinical intravital microscopy findings to more clinically applicable imaging modalities such as CT or MRI.
临床前活体成像技术,如显微镜和光学相干断层扫描,已被证明是癌症研究中用于可视化肿瘤微环境及其对治疗反应的有价值的工具。这些成像方式具有微米级分辨率,但由于其在组织中的穿透深度有限,在临床上的应用有限。更适用于临床的成像方式,如 CT、MRI 和 PET,具有更大的穿透深度,但空间分辨率相对较低(毫米级)。为了将临床前活体成像研究结果转化为临床应用,必须开发新的方法来弥合这种微观到宏观分辨率的差距。在这里,我们描述了一种背侧皮肤窗室肿瘤小鼠模型,该模型旨在使临床前活体和临床适用(CT 和 MRI)成像在同一动物中得以实现,并描述了将这两种不同可视化方法联系起来的图像分析平台。重要的是,所描述的窗室方法能够使用窗室上的基准标记以 3D 方式对不同的成像方式进行配准,以实现直接的空间一致性。该模型可用于验证现有的临床成像方法,也可通过与“真实”高分辨率活体发现的直接相关性来开发新的方法。最后,可使用这种方法通过临床前和临床适用的成像方式对各种治疗方法(化疗、放疗、光动力疗法)的肿瘤反应进行纵向监测。因此,这里描述的背侧皮肤窗室肿瘤小鼠模型和成像平台可用于各种癌症研究,例如,将临床前活体显微镜研究结果转化为更适用于临床的成像方式,如 CT 或 MRI。